Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Hydralazine on the Early Stage of Alzheimer's Disease: A Randomized Clinical Trial

NCT04842552 is registered in ClinicalTrials.gov with Shahid Sadoughi University of Medical Sciences and Health Services as lead sponsor.

NCT NCT04842552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Hydralazine on the Early Stage of Alzheimer's Disease: A Randomized Clinical Trial
Lead sponsor
Shahid Sadoughi University of Medical Sciences and Health Services
Phase
Phase 3
Overall status
Completed
Start date
August 2, 2021
Completion date
March 5, 2026
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease